TransCode amends preferred stock certificate to remove 60-day notice for ownership limit changes

Transcode Therapeutics, Inc.

Second Amended and Restated Certificate of Designation filed on August 3, 2026.
Removes 60-day notice requirement to change or waive beneficial ownership limitation.
No other changes to the certificate; no additional securities issued or sold.
Amendment approved by majority of preferred stockholders and Board of Directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.